awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38811111-7F257D49-6D65-4B39-A3E9-632D7A01C7BA
Q38811111-7F257D49-6D65-4B39-A3E9-632D7A01C7BA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38811111-7F257D49-6D65-4B39-A3E9-632D7A01C7BA
Treating IgE-mediated diseases via targeting IgE-expressing B cells using an anti-CεmX antibody.
P2860
Q38811111-7F257D49-6D65-4B39-A3E9-632D7A01C7BA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38811111-7F257D49-6D65-4B39-A3E9-632D7A01C7BA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
513664a11d3a04bb893511c6d1a29622e84449e0
P2860
Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects.